Incorporating Alcohol Pharmacotherapies into Medical Practice

 

Alcohol use disorder is a primary health condition that interacts with and complicates many other health problems and psychiatric disorders. Unfortunately, only a small number of people with alcohol use disorder receive appropriate treatment for substance use issues. The U.S. Food and Drug Administration (FDA) has approved four medications to treat alcohol use disorder, making treatment in primary care and other general medical settings a viable alternative to specialty care. This course will give you valuable information about these medications as well as a number of medications used off-label, empowering those you serve and increasing the likelihood of their recovery. Through interactive lessons and descriptive examples, you will learn about how these medications work and review recommended guidelines for treatment of alcohol use disorder. The target audience for this course is prescribers, although it will be informative for anyone who wants to better understand medication-assisted treatment (e.g. substance use disorder professionals, consumers, families, and mental health providers). As you proceed through the course, keep in mind several key facts: • Alcohol use disorder is a real and serious health condition. • Alcohol use disorder is identifiable and treatable in routine medical care settings. • Treatment is essential and recovery is very real - not a remote possibility. • Medications are increasingly available and effective in the right circumstances.

$19.95

Hours: 1.50
REL-HHS-0-IAPMP

Certificates

Certificates provided by accrediting body (29 Match)

American Psychological Association

1.5 HOURS


Relias, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists. Relias, LLC maintains responsibility for this program and its content. This activity is approved for 1.50 contact hours.

California Board of Registered Nursing

1.5 HOURS


Provider approved by the California Board of Registered Nursing, CEP# 13791

Nurses will receive 1.50 contact hours for participating in this course.

District of Columbia Board of Nursing

1.5 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 1.50 contact hours for participating in this course.

Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling

1.5 HOURS


Provider #50-290 This activity is approved for 1.50 contact hours.

Illinois Professional Counselor/Clinical Counselor

1.5 HOURS


This activity is approved for 1.50 contact hours.

National Board for Certified Counselors

2.0 HOURS







Relias, LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No.6110. Programs that do not qualify for NBCC credit are clearly identified. Relias , LLC is solely responsible for all aspects of the programs. This activity is approved for 2.00 contact hours

Ohio Marriage and Family Therapist Board

1.5 HOURS


Provider # RTX050401
This activity is approved for 1.50 contact hours.

Ohio Professional Counselor Board

1.5 HOURS


Provider # RCX100502 290
This activity is approved for 1.50 contact hours.

Texas State Board of Professional Counselors

1.5 HOURS


This activity is approved for 1.50 contact hours.

Florida Board of Nursing CE

1.5 HOURS


Florida Board of Nursing CE Provider #: 50-290

Nurses will receive 1.50 contact hours for participating in this course.

Texas State Board of Examiners of Marriage and Family Therapists

1.5 HOURS


This activity is approved for 1.50 contact hours.

American Nurses Credentialing Center

1.5 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 1.50 contact hours for participating in this course.

Association of Social Work Boards

1.5 HOURS


Relias, LLC, #1273, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org, through the Approved Continuing Education (ACE) program. Relias, LLC maintains responsibility for the program. ASWB Approval Period: 2/10/2018-2/10/2021. Social workers should contact their regulatory board to determine course approval for continuing education credits.

Course Delivery Format: Asynchronous Distance Learning-interaction includes quizzes with questions and answers, posttests. This module is Text-based.

Social workers participating in this course will receive 1.50 Clinical continuing education clock hours.

New York State Education Department, Office of the Professions, Division of Professional Licensing Services, Social Work Unit

1.5 HOURS


Relias, LLC is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0009.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of licensed master social work and licensed clinical social work in New York. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice for an LMSW and LCSW. A licensee who practices beyond the authorized scope of practice could be charged with unprofessional conduct under the Education Law and Regents Rules.

As a provider of online, asynchronous education, some courses offered by Relias Learning are considered “self-study” under section 74.10(c)(2)(ii)(b)(4) of the Commissioner’s Regulations. The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.

Social workers will receive 1.50 continuing education hours for participating in this course. This activity is approved for 1.50 contact hours.

Florida Board of Psychology

1.5 HOURS


Georgia Board of Nursing

1.5 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 1.50 contact hours for participating in this course.

Illinois, Department of Financial and Professional Regulation, Marriage and Family Therapist Continuing Education Sponsor

1.5 HOURS


This activity is approved for 1.50 contact hours.

Louisiana Addictive Disorder Regulatory Authority

1.5 HOURS


This activity is approved for 1.50 contact hours.

Michigan Certification Board for Addiction Professionals

1.5 HOURS


Education hours MCBAP-S
This activity is approved for 1.50 contact hours.

NAADAC, The Association for Addiction Professionals

1.5 HOURS


This course has been approved by Relias LLC, as a NAADAC Approved Education Provider, for 1.50 CE. NAADAC Provider #86124, Relias, LLC is responsible for all
aspects of their programming.

Breining Institute for Registered Addiction Specialists

1.5 HOURS


This activity is approved for 1.50 contact hours.

California Consortium of Addiction Programs and Professionals

1.5 HOURS


Provider approved by CCAPP, Provider number 1S-06-729-0220 for 1.50 CEH's

Missouri Credentialing Board

1.5 HOURS


This activity is approved for 1.50 contact hours.

Ohio Chemical Dependency Professionals Board

1.5 HOURS


This activity is approved for 1.50 contact hours. Content Area: C6, C8, R1

Connecticut Certification Board

1.5 HOURS


This activity is approved for 1.50 contact hours.

Accreditation Council for Continuing Medical Education

1.5 HOURS


Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Relias LLC designates this enduring material activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Florida Board of Medicine

1.5 HOURS


Florida Board of Medicine CE Provider #: 50-290

Florida Physician Assistants

1.5 HOURS


Illinois Alcohol and Drug Abuse Professional Certification Association

1.5 HOURS


Categories Counselor I or II, Preventionist I or II, CARS I or II, CODP I or II, PCGC II, CCJP II, CAAP I, CRSS I or II, CPRS I or II, MAATP I or II, NCRS II, CFPP II, CVSS II
This activity is approved for 1.50 contact hours.

Course Details

Course Code: REL-HHS-0-IAPMP
Hours: 1.5
Type: Online Course
Content Expiration Date: 1/31/2019
Learning Objectives:
Identify the benefits of treating alcohol use disorder in a medical setting.
Conduct screenings and brief interventions to treat individuals who have alcohol use disorder.
Determine which type of alcohol pharmacotherapy is most appropriate for a given individual based on their medical background and lifestyle choices.

Outline:
Section 1: Introduction
A. About This Course
B. Learning Objectives
Section 2: Treating Alcohol Use Disorder in Medical Settings
A. What Is Normal?
B. Alcohol Use Disorder in Medical Settings
C. Cost of Alcohol Use Disorder
D. Treating Alcohol Use Disorder
E. Accessing Treatment in a General Medical Setting
F. Initiating Treatment in a General Medical Setting vs. Specialty Treatment
G. Benefits of Initiating Treatment in a General Medical Setting
H. Why Use Medications to Treat Alcohol Use Disorder?
I. Benefits to Medication-Assisted Treatment
J. Meet Gerald
K. Section Summary
Section 3: Medications for Treating Alcohol Use Disorder
A. What Medications Are Used in Treatment of Alcohol Use Disorder?
B. How Medications Come to Be Approved
C. Overview of FDA Approved Medications
D. Section Summary
Section 4: Acamprosate
A. Acamprosate at a Glance
B. What is Acamprosate?
C. Pharmacology
D. Why Use Acamprosate?
E. Acamprosate’s Safety Profile
F. Advantages of Using Acamprosate
G. Who Is Appropriate for Treatment with Acamprosate?
H. How is Acamprosate Used?
I. How Effective Is Acamprosate?
J. Side Effects of Acamprosate
K. Contraindications and Cautions of Acamprosate
L. Consumer Education
M. Discontinuing Acamprosate
N. Meet Richard
O. Section Summary
Section 5: Oral Naltrexone
A. Oral Naltrexone at a Glance
B. What is Oral Naltrexone?
C. Pharmacology
D. Why Use Oral Naltrexone?
E. Oral Naltrexone’s Safety Profile
F. Who Is Appropriate for Treatment with Oral Naltrexone?
G. How Is Oral Naltrexone Used?
H. Oral Naltrexone Dosages
I. Oral Naltrexone Side Effects
J. Contraindications and Cautions of Oral Naltrexone
K. Consumer Education
L. Discontinuing Oral Naltrexone
M. Meet Vincent
N. Section Summary
Section 6: Extended-Release Injectable Naltrexone
A. Extended-Release Injectable Naltrexone at a Glance
B. What Is Extended-Release Injectable Naltrexone?
C. Pharmacology
D. Why Use Extended-Release injectable Naltrexone?
E. Major Benefit of Extended-Release Injectable Naltrexone
F. Extended-Release Injectable Naltrexone’s Safety Profile
G. Who Is Appropriate for Treatment with Extended-Release Injectable Naltrexone?
H. How Is Extended-Release Injectable Naltrexone Used?
I. Side Effects of Extended-Release Injectable Naltrexone
J. Contraindications and Cautions of Extended-Release Injectable Naltrexone
K. Consumer Education
L. Discontinuing Extended-Release Injectable Naltrexone
M. Remember Vincent
N. Section Summary
Section 7: Disulfiram
A. Disulfiram at a Glance
B. What Is Disulfiram?
C. Pharmacology
D. Possible Effects of the Disulfiram-Alcohol Reaction
E. Why Use Disulfiram?
F. Disulfiram’s Safety Profile
G. Who Is Appropriate for Treatment with Disulfiram?
H. How Is Disulfiram Used?
I. Disulfiram Dosage
J. Side Effects of Disulfiram
K. Contraindications and Cautions of Disulfiram
L. Consumer Education
M. Discontinuing Disulfiram
N. Meet Angela
O. Section Summary
Section 8: Off-Label Medication Use
A. Off-Label Prescribing
B. Prevalence of Off-Label Prescribing in Medicine
C. Off-Label Prescribing in Alcohol Use Disorder Treatment
D. Medications: Mood Stabilizers and Anticonvulsants
E. Medications: Serotonin
F. Medications: Dopamine
G. Section Summary
Section 9: Consumer Management
A. Integrating Medication for Alcohol Use Disorder into Clinical Practice Settings
B. Initial Assessment
C. Recommended Assessments
D. Choosing a Medication
E. Choosing a Psychosocial Intervention
F. Types of Psychosocial Therapies
G. Developing a Treatment Plan
H. Consumer Awareness
I. Monitoring Consumer Progress
J. Section Summary
Section 10: Conclusion
A. Summary
B. Course Contributors
C. References
D. Exam

Expert Reviewer: John Santopietro, MD
Dr. John Santopietro is Chief Medical Officer at Community Health Resources, a community mental health and substance abuse agency that provides care to 10,000 patients a year. He has held administrative and clinical positions in community mental health, hospital-based mental health, and state-run mental health systems. Dr. Santopietro received his BA from Yale University and his MD from Northwestern University Medical School. He completed his internship/residency in psychiatry at Cambridge Hospital, Harvard University Medical School, and went on for a fellowship at the Austin Riggs Center, Harvard University Medical School. He is board certified by the American Board of Psychiatry and Neurology and a Fellow of the American Psychiatric Association, President–Elect of the Connecticut Psychiatric Society, and a member of the American Association of Community Psychiatrists, the American Society of Addiction Medicine, and the American College of Physician Executives. He is a clinical instructor in the Department of Psychiatry, University of Connecticut School of Medicine, and teaches medical students and residents in psychiatry. Dr. Santopietro also serves as a gubernatorial appointee on the State of Connecticut’s Department of Mental Health and Addictions advisory board. Disclosure: John Santopietro, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Instructor: Mark Witte, LMSW, LMFT
This course was written by Mark Witte, LMSW. Mr. Witte serves as the Director of Substance Abuse Services for the Lakeshore Regional Partners in West Michigan. Mark holds a BA in Sociology and an MSW in Social Work. He worked for nearly 20 years in children’s services, and since 2004, has gained extensive experience in substance use prevention, treatment, and recovery support services. Mark serves as an adjunct professor of social work at several colleges and serves on boards for the Great Lakes Addiction Technology Transfer Center and the Michigan Drug Treatment Court Advisory Committee. Disclosure: Mark Witte, LMSW, LMFT has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Instructor: David Patzer, MD
David Patzer, M.D. has been practicing child, adolescent, and adult psychiatry for nearly 20 years. His education includes an undergraduate degree from Illinois Wesleyan University and a medical degree from Northwestern Medical School in Chicago, Illinois. He completed residency training in General Adult Psychiatry at Yale University and Child and Adolescent Psychiatry Fellowship training at the Yale University Child Study Center. Dr. Patzer served as Assistant Professor at Yale and subsequently at the University of Arizona in Tucson teaching child psychiatry. He also attended the Addiction Psychiatry Fellowship at Vanderbilt University. Dr. Patzer is board certified in general psychiatry, child and adolescent psychiatry, and addiction medicine, as well as licensed for practice in both Tennessee and Arizona. He has served in numerous director-level positions for child and adolescent psychiatry. He has also published numerous articles on developmental disorders and substance use disorders. Dr. Patzer currently serves as the Adult and Child and Adolescent Psychiatrist and Clinical Supervisor for Mental Health Cooperative in Nashville, Tennessee. He is also the Medical Director for the Middle Tennessee Bradford Health Services (Addiction Treatment) in Nashville, Franklin, and Clarksville, Tennessee. Disclosure: David Patzer, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: entry and intermediate level Nurses; entry and intermediate level Social Workers; entry level Alcohol and Drug Counselors; entry level Professional Counselors; entry level Psychologists; in the following settings: Health and Human Services.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support by calling (800) 381-2321 or emailing support@relias.com